Insider Transaction Report for Karlin Daniel

Karlin Daniel, Chief Medical Officer of Definium Therapeutics, Inc. (DFTX), reported a sale of 10,035 common shares on June 25, 2026. The shares were sold at a price of $45.03 per share, totaling $451,800.45. This transaction was conducted under a Rule 10b5-1 plan adopted on June 14, 2022, to satisfy tax withholding obligations related to the settlement of vested restricted stock units. Following this transaction, Mr. Daniel directly owns 503,282 shares of common stock. The filing is Form 4, indicating a change in beneficial ownership.